Rxivist logo

A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome

By Fan Gao, Xuedong Pan, Elissa B Dodd-Eaton, Carlos Vera Recio, Matthew D Montierth, Jasmina Bojadzieva, Phuong L Mai, Kristin Zelley, Valen E Johnson, Danielle Braun, Kim E. Nichols, Judy E Garber, Sharon A. Savage, Louise C Strong, Wenyi Wang

Posted 11 Feb 2020
bioRxiv DOI: 10.1101/2020.02.10.942409 (published DOI: 10.1101/gr.249599.119)

De novo mutations (DNMs) are increasingly recognized as rare disease causal factors. Identifying DNM carriers will allow researchers to study the likely distinct molecular mechanisms of DNMs. We developed Famdenovo to predict DNM status (DNM or familial mutation (FM)) of deleterious autosomal dominant germline mutations for any syndrome. We introduce Famdenovo.TP53 for Li-Fraumeni syndrome (LFS) and analyze 324 LFS family pedigrees from four US cohorts: a validation set of 186 pedigrees and a discovery set of 138 pedigrees. The concordance index for Famdenovo.TP53 prediction was 0.95 (95% CI: [0.92, 0.98]). Forty individuals (95% CI: [30, 50]) were predicted as DNM carriers, increasing the total number from 42 to 82. We compared clinical and biological features of FM versus DNM carriers: 1) cancer and mutation spectra along with parental ages were similarly distributed; 2) ascertainment criteria like early-onset breast cancer (age 20 to 35 years) provides a condition for an unbiased estimate of the DNM rate: 48% (23 DNMs versus 25 FMs); 3) hotspot mutation R248W was not observed in DNMs, although it was as prevalent as hotspot mutation R248Q in FMs. Furthermore, we introduce Famdenovo.BRCA for hereditary breast and ovarian cancer syndrome, and apply it to a small set of family data from the Cancer Genetics Network. In summary, we introduce a novel statistical approach to systematically evaluate deleterious DNMs in inherited cancer syndromes. Our approach may serve as a foundation for future studies evaluating how new deleterious mutations can be established in the germline, such as those in TP53 . ### Competing Interest Statement The authors have declared no competing interest.

Download data

  • Downloaded 404 times
  • Download rankings, all-time:
    • Site-wide: 123,884
    • In genetics: 4,622
  • Year to date:
    • Site-wide: 191,183
  • Since beginning of last month:
    • Site-wide: 177,241

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide